According to MARTIN MIDSTREAM PARTNERS L.P.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 10:56 AM, company Director, Taylor Sharon L disclosed buying 416 shares at a cost of $2.91. At the time of this transaction (Jan 11), this trade was worth $1,212 in total. […]
According to MARTIN MIDSTREAM PARTNERS L.P.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 10:56 AM, company Chief Medical Officer, Martin Ruben S disclosed buying 485 shares at a cost of $2.91. At the time of this transaction (Jan 11), this trade was worth $1,413 […]
According to Anixa Biosciences Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:54 AM, company Director, Titterton Lewis H Jr disclosed buying 2,000 shares at a cost of $3.20. At the time of this transaction (Jan 11), this trade was worth $6,400 in total. […]
According to AMN HEALTHCARE SERVICES INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:28 PM, company Chief Executive Officer, Salka Susan R disclosed selling 14,309 shares at a cost of $109.47. At the time of this transaction (Jan 10), this trade was worth $1,566,361 […]
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:16 PM, company Chief Accounting Officer, Whitten Jessica disclosed selling 279 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $2,690 in total. […]
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 3,387 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $32,659 in total. […]
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 1,584 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $14,893 in total. […]
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Director, Leschly Nick disclosed selling 5,068 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $48,869 in total. As of […]
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company Director, Leschly Nick disclosed selling 2,369 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $22,274 in total. As of […]
According to bluebird bio, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 09:15 PM, company President and CEO, Obenshain Andrew disclosed selling 4,683 shares at a cost of $9.64. At the time of this transaction (Jan 11), this trade was worth $45,156 in total. […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
